Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7673)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 28, 2024 (publication date) through Dec 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Christodoulidis G, Koumarelas KE, Kouliou MN. Revolutionizing gastric cancer treatment: The potential of immunotherapy. World J Gastroenterol 2024; 30(4): 286-289 [PMID: 38313231 DOI: 10.3748/wjg.v30.i4.286] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Christodoulidis G, Koumarelas KE, Kouliou MN. Revolutionizing gastric cancer treatment: The potential of immunotherapy. World J Gastroenterol 2024; 30(4): 286-289 [PMID: 38313231 DOI: 10.3748/wjg.v30.i4.286] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i4/286.htm |
| Number | Citing Articles |
| 1 |
Gabriel Samasca, Claudia Burz, Irena Pintea, Adriana Muntean, Diana Deleanu, Iulia Lupan, Vasile Bintintan. A New Medical Evaluation for Gastric Cancer Patients to Increase the Success Rate of Immunotherapy: A 2024 Update. Pharmaceuticals 2024; 17(9): 1121 doi: 10.3390/ph17091121
|
| 2 |
Guodong Liang, Yuehan Ma, Ping Deng, Shufeng Li, Chunyan He, Haihang He, Hairui Liu, Yunda Fan, Ze Li. Role of cell-based therapies in digestive disorders: Obstacles and opportunities. Regenerative Therapy 2025; 29: 1 doi: 10.1016/j.reth.2025.02.009
|
| 3 |
Sourav Basak, Subhasis Chakrabarty, Joyeeta Bhattacharya, Kaustav Dutta, Arghya Kusum Dhar, Narahari N. Palei. Theranostics in Cancer Management. 2026; : 43 doi: 10.1016/B978-0-443-34199-1.00009-0
|
| 4 |
Zijie Wei, Ziqian Kou, Yun Luo, Yu Cheng. DNA methyltransferase 3A: A prognostic biomarker and potential target for immunotherapy in gastric cancer. Medicine 2025; 104(7): e41578 doi: 10.1097/MD.0000000000041578
|
| 5 |
Yuxin Huang, Yi Hu. Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancer. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14436-x
|
| 6 |
Chao Xiong, Zhuo Chen, Xian Wu, Caiyun Zhang, Zijun Yuan, Xiang Wang, Zhangang Xiao, Yu Chen, Shuai Deng, Xu Wu, Mingxing Li, Fukuan Du, Yueshui Zhao, Xiaobing Li, Xi He, Jing Shen. The impact of multidimensional interactions among Helicobacter pylori infection, tumor microenvironment, and gut microbiota on gastric cancer immune response. European Journal of Pharmacology 2025; : 178401 doi: 10.1016/j.ejphar.2025.178401
|
| 7 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 8 |
Jane E. Rogers, Qiong Gan, Rebecca E. Waters, Ashley A. Horak, Jaffer A. Ajani. Targeted and combination immunotherapies using biologics for gastric cancer: the state-of-the-art. Expert Opinion on Biological Therapy 2024; 24(10): 1005 doi: 10.1080/14712598.2024.2401622
|
| 9 |
Hui Yuan, Miao Bao, Minqiang Chen, Junhao Fu, Shian Yu. Advances in Immunotherapy and Targeted Therapy for Gastric Cancer: A Comprehensive Review. British Journal of Hospital Medicine 2025; 86(3): 1 doi: 10.12968/hmed.2024.0759
|
| 10 |
Ruoxi Tian, Siqi Wang, Zhengzheng Ji, Jiasong Li, Jingjing Zhang, Shasha Zhang, Zhanjun Guo. Association between emotional distress and the efficacy of advanced gastric cancer patients undergoing treatment with immune checkpoint inhibitors: a cohort study and propensity score matching study. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1516643
|
| 11 |
Yuhang Liu, Haoyu Yun, Wei Zhang, Han Zou, Nuojun Chen, Yutong Wang, Zining Luo, Xinyu Xu, Yixin Sun, Yuquan Chen, Andriy Beznosenko, Hussein ALMasri, Morgan A. McClure, Haowei Ma, Jiang Yu, Qijun Lv. Robotic versus laparoscopic total gastrectomy for gastric cancer: a systematic review and meta-analysis of perioperative and oncologic outcomes. International Journal of Surgery 2025; 111(9): 6397 doi: 10.1097/JS9.0000000000002761
|
| 12 |
Wen Pan, Ying Tan, Xiaohong Chen, Li Zeng, Yuetong Lv, Jinlin Yang. miRNA-204-5p acts as a tumor suppressor in gastric cancer by inhibiting cell migration, invasion, and glycolysis via the RAB22A/PI3K/AKT axis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-02139-z
|
| 13 |
Hongrong Zhang, Yufan Li, Ya Li. Elucidating the multiscale mechanisms and therapeutic targets of caffeic acid in gastric cancer: a synergy of computational and experimental approaches. Frontiers in Molecular Biosciences 2025; 12 doi: 10.3389/fmolb.2025.1663517
|
| 14 |
Ruijuan Xin, Xiaoqin Ma, Min Niu, Qian Hao, Hongliang Li, Linke Ma, Shengjuan Hu. Comprehensive long-read transcriptomic analysis reveals multi-level transcriptional alterations mediated by miR-214-3p dysregulation in gastric cancer cells. BMC Cancer 2025; doi: 10.1186/s12885-025-15323-1
|
| 15 |
Obed Boadi Amissah, Rajesh Basnet, Wenfang Chen, Jean de Dieu Habimana, Belinda Edwina Baiden, Osei Asibey Owusu, Babangida Jabir Saeed, Zhiyuan Li. Enhancing antitumor response by efficiently generating large-scale TCR-T cells targeting a single epitope across multiple cancer antigens. Cellular Immunology 2024; : 104827 doi: 10.1016/j.cellimm.2024.104827
|
| 16 |
Xiaodan Jiang, Xun Li, Yang Li, Yu Zhang, Xinliang Gu, Wei Zong, Xianjuan Shen, Shaoqing Ju. Systematic assessment of serum i-tRF-AsnGTT in gastric cancer: a potential clinical biomarker. Carcinogenesis 2025; 46(1) doi: 10.1093/carcin/bgae044
|
| 17 |
Yang-Kun Wang, Ping Li, Hai-Ying He, Fa-Shun Zhang, Xiao-Ling Jiang, Ren-Bing Zhang, Su-Nan Wang, Si-Liang Xu. Relationship between gastric mucosal atrophy, cystic dilatation, and histopathological characteristics. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03662-z
|
| 18 |
Margherita Ratti, Elena Orlandi, Ilaria Toscani, Stefano Vecchia, Elisa Anselmi, Jens Claus Hahne, Michele Ghidini, Chiara Citterio. Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review. Cancers 2024; 16(15): 2692 doi: 10.3390/cancers16152692
|
| 19 |
Fares E.M. Ali, Islam M. Ibrahim, Hanan S. Althagafy, Emad H.M. Hassanein. Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review. International Immunopharmacology 2024; 132: 112011 doi: 10.1016/j.intimp.2024.112011
|
| 20 |
Jin Liu, Xiu Zhang, Xiao Hu, Gaofeng Yuan, Kai Chen. CLDN9 Levels Influence the Biological Activities of Cells in Gastric Cancer. BIOCELL 2025; 49(4): 665 doi: 10.32604/biocell.2025.063296
|
| 21 |
Yonggang Tian, Yunqian Xie, Guirong Yi, Fanqi Wu, Xiaoyu Dang, Feihu Bai, Jun Wang, Dekui Zhang. Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer. Current Medicinal Chemistry 2024; 31(42): 7043 doi: 10.2174/0109298673315146240731100101
|
| 22 |
Bo-Ya Li, Hui-Ling Li, Fei-Er Zeng, Xuan-Yu Luan, Bi-Qing Liu, Zhi-Zhou Wang, Lan Zhang, Xian-Zhe Dong. Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02515-1
|
| 23 |
Leila Mohajeri, Reza Daghayeghi, Navid Rostami, Yasamin Moeinipour, Reza Hossein zadeh, Raoul Hossein Zadeh, Reza Shah Hosseini, Mohsen Jabbari, Komeil Aghazadeh Habashi, Niloofar Deravi. Early oral feeding after laparoscopic total gastrectomy in gastric cancer patients: a meta-analysis of randomized controlled trials and cohort studies. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04283-2
|
| 24 |
Ji-Yun Wan, Duo Zhang, Xiang-Hua Wu, Hao Yang, Chao Dong. Progress of immune checkpoint inhibitors in gastric cancer. World Journal of Gastrointestinal Oncology 2025; 17(8): 109613 doi: 10.4251/wjgo.v17.i8.109613
|
| 25 |
Ming Zhou, Xiaozhe Mao, Kanger Shen, Qin Zhan, Haoxiang Ni, Chun Liu, Ziyi Huang, Rui Li. FBLN2 inhibits gastric cancer proliferation and metastasis via the TGFβ/TGIF2 pathway. Pathology - Research and Practice 2025; 269: 155899 doi: 10.1016/j.prp.2025.155899
|
| 26 |
Longfeng Zhang, Qingsheng Yang, Zhiwei Zheng. Cost-effectiveness analysis of cadonilimab plus chemotherapy as a first-line treatment option in HER-2-negative advanced gastric cancer. Frontiers in Public Health 2025; 13 doi: 10.3389/fpubh.2025.1644176
|
| 27 |
Qiong Luo, Sheng Yang, Qian Xu. NCAPD2 Modulates MHC-I Antigen Presentation via the PI3K/AKT Axis to Drive Metastatic Progression in Gastric Cancer. Digestive Diseases and Sciences 2025; doi: 10.1007/s10620-025-09402-3
|